Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
Study NCT ID:
NCT00135369
Status:
COMPLETED
Last Update Posted:
2011-04-25
First Post:
2005-08-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09
Start Date Type:
None
Primary Completion Date:
2005-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-08
Last Update Post Date:
2011-04-25
Last Update Post Date Type:
ESTIMATED